| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/16/2006 | US20060035385 Azo-coupling residue to a target compound capable of producing a detectable signal, identifying a nitroderivative compound for assessing in vivo nitrative stress and for aiding in diagnosis of mammalian pathologies, asthma, atherosclerosis, Alzheimer's disease, inflammation, ischemia, Parkinson's |
| 02/16/2006 | US20060035384 Instrument |
| 02/16/2006 | US20060035383 Dry platelet preparations for use in diagnostics |
| 02/16/2006 | US20060035380 Fake-proof marking of a composition |
| 02/16/2006 | US20060035373 Stem cell libraries |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035328 Artery-and vein-specific proteins and uses therefor |
| 02/16/2006 | US20060035322 T-cell epitopes in erythropoietin |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035303 JNK3 modulators and methods of use |
| 02/16/2006 | US20060035298 System and method for determining a coagulation parameter |
| 02/16/2006 | US20060035297 Reagents and methods for mycophenolic acid immunoassay |
| 02/16/2006 | US20060035296 Method for detecting acetyltransferase and deacetylase activities and method for screening inhibitors or enhancers of these enzymes |
| 02/16/2006 | US20060035295 Method for determination of thymidine kinase 1 activity and the use thereof |
| 02/16/2006 | US20060035294 Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035292 Differential diagnosis of cancer and other conditions based on expression of p63 |
| 02/16/2006 | US20060035291 Method of detecting cellular immunity and application thereof to drugs |
| 02/16/2006 | US20060035290 Isolation of endothelial progenitor cell subsets and methods for their use |
| 02/16/2006 | US20060035289 Affinity fluorescent proteins and uses thereof |
| 02/16/2006 | US20060035288 Methods for detection of counterfeit liquids and foods |
| 02/16/2006 | US20060035287 Immunoassay for detecting presence of antibodies against Lawsonia intracellularis; for early detection of Porcine proliferative enteritis; ELISA |
| 02/16/2006 | US20060035286 Monitor protein for measuring processing of protein |
| 02/16/2006 | US20060035285 Method for identifying modulators of human orexin-2 receptor |
| 02/16/2006 | US20060035284 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 02/16/2006 | US20060035283 Prophylaxis and therapy of diseases or disorders related to glutamate excitotoxicity, caused by cerebral infarcts, head trauma, seizures, and anoxia; disorders related to NMDA receptor glutamate excitotoxicity, including for example, cerebral ischemia, Parkinson's disease, Huntington's disease |
| 02/16/2006 | US20060035282 Assessment of serum and/or urine calcium levels by determining the concentration of parathyroid hormone (PTH) agonist and that of PTH antagonist in a sample; comparingand averaging ratios; amino acid sequences of both; diagnosis/medical/; prognosis; metabolism/absorption of calcium calculi |
| 02/16/2006 | US20060035281 Methods and systems for generating peptides |
| 02/16/2006 | US20060035280 Screening methods for inhibitors of protein-protein binding interactions |
| 02/16/2006 | US20060035279 Anti-GPE antibodies, their uses and assays for weakly immunogenic molecules |
| 02/16/2006 | US20060035278 Methods and compositions for modulating HGF/Met |
| 02/16/2006 | US20060035277 Capture arrays using polypeptide capture agents |
| 02/16/2006 | US20060035276 Membrane protein library for proteome analysis and method for preparing same |
| 02/16/2006 | US20060035274 Complexity management of genomic DNA |
| 02/16/2006 | US20060035270 Unique recognition sequences and methods of use thereof in protein analysis |
| 02/16/2006 | US20060035267 Targets tumor specific antigens; antigens comprise GM2, fucosyl GM1, globo H and N-propionylated polysialic acid conjugated to immunomodulating carrier keyhole limpet hemocyanin, and adjuvant QS-21 or GPI-0100; optimal combination determined by cell surface reactivity; small cell lung cancer |
| 02/16/2006 | US20060035264 Processes for incorporating nucleic acid sequences into an analyte or library of analytes |
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/16/2006 | US20060035259 Method and apparatus for detecting structural elements of subjects |
| 02/16/2006 | US20060035258 Methods for identifying DNA copy number changes |
| 02/16/2006 | US20060035253 Method and apparatus for analysing nucleic acid sequence |
| 02/16/2006 | US20060035252 Methods and workflows for selecting genetic markers utilizing software tool |
| 02/16/2006 | US20060035248 Assays employing electrochemiluminescent labels and electrochemiluminescence quenchers |
| 02/16/2006 | US20060035247 Biochip with radio frequency identification tag attached thereto, hybridization system, and hybridization management method |
| 02/16/2006 | US20060035239 Method and compositions for treating diseases targeting CD51 |
| 02/16/2006 | US20060035238 Composition comprising an array which further comprises chimeric compositions |
| 02/16/2006 | US20060035237 Methods and compositions for categorizing patients |
| 02/16/2006 | US20060035234 detecting molecules and molecular interaction events, retrieving and analyzing analytes, and delivering substances to cells or tissues using probes of the invention |
| 02/16/2006 | US20060035223 Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby |
| 02/16/2006 | US20060035221 Use of the glycine n-acyl transferase (gnat) for the diagnosis and therapy of inflammatory diseases and sepsis |
| 02/16/2006 | US20060035219 Aberrant kallikrein expression |
| 02/16/2006 | US20060035217 Binary probe and clamp composition. |
| 02/16/2006 | US20060035216 recombinant nucleic acid; isotopic, fluorescent, chemiluminescent, enzymatic, or hapten probe; cloning vector of the nucleic acid; host cell with improved exogenous expression of the nucleic acid; biodegradation; pollution control |
| 02/16/2006 | US20060035215 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment; kits |
| 02/16/2006 | US20060035213 POSH nucleic acids, polypeptides and related methods |
| 02/16/2006 | US20060035212 Molecules inhibiting hepatitis c virus protein synthesis and method for screening same |
| 02/16/2006 | US20060035211 Methods for identifying conditions affecting a cell state |
| 02/16/2006 | US20060035209 Screening method |
| 02/16/2006 | US20060035208 Method for fixing a protein on a pyrrole-based polymer and use thereof for making a sensor |
| 02/16/2006 | US20060034862 Method for diagnosing early and late lyme borreliosis |
| 02/16/2006 | US20060034861 HCV E1 comprising specific disulfide bridges |
| 02/16/2006 | US20060034859 Naturally processed measles virus peptides eluted from class II HLA molecules |
| 02/16/2006 | US20060034858 A beta or an immunogenic fragment thereof presented by a virus or bacteria as part of an immunogenic composition effective to induce an immunogenic response comprising antibodies against A beta |
| 02/16/2006 | US20060034857 Administering an isolated polynucleotide encoding a Notch ligand comprising a Delta Serrate Ligand (DSL) domain to a cell of a patient; the Notch ligand is expressed and interacts with a Notch receptor to reduce T-cell activation; antiallergens; graft rejection; autoimmune disease |
| 02/16/2006 | US20060034848 Methods and compositions for treating Alzheimer's disease |
| 02/16/2006 | US20060034838 Anti-human VEGF receptor Flt-1 monoclonal antibody |
| 02/16/2006 | US20060034837 Method and agents for the prevention, inhibition and therapy of cancers |
| 02/16/2006 | US20060034807 Innervated artificial tissues and uses thereof |
| 02/16/2006 | US20060034772 Composition comprising low density microspheres |
| 02/16/2006 | US20060034767 Targeting and tracking of cells to specific organs and tissues in vivo |
| 02/16/2006 | US20060034762 Method for measuring skin absorbability |
| 02/16/2006 | US20060034728 Methods and apparatus for analyzing an analysis fluid |
| 02/16/2006 | US20060034726 Multiple sensing system and device |
| 02/16/2006 | US20060034725 Apparatus and method for aligning a microarray printing head |
| 02/16/2006 | US20060033910 Multiplexed detection of analytes in fluid solution |
| 02/16/2006 | US20060032825 Blood components separator disk |
| 02/16/2006 | US20060032750 Method for producing matrices of addressed ligands on a carrier |
| 02/16/2006 | US20060032742 Laminated membranes for diffusion limited gas sensors resistant to pressure variations |
| 02/16/2006 | DE202005017829U1 Analytical device comprising carrier in housing with window for observing results on the carrier, e.g. in body fluid analyses, and having visual contrast between carrier and housing to facilitate reading of results |
| 02/16/2006 | DE19943861B4 Heizvorrichtung ohne Wood-Metall, die die Flüchtigkeitsmessung nach Noack einer Flüssigkeitsprobe eines Petroleumproduktes, hauptsächlich eines Schmieröls, erlaubt und Verfahren unter Anwendung dieser Vorrichtung Wood-metal without heating device, the Noack a liquid sample of a petroleum product, especially a lubricating oil allows the Flüchtigkeitsmessung and method using this device, |
| 02/16/2006 | DE19839398B4 Mini-Basket zur Untersuchung der Wirkstofffreisetzung aus einer Arzneiform Mini-Basket for the investigation of drug release from a pharmaceutical form |
| 02/16/2006 | DE102005028900A1 To identify and diagnose ischemic heart damage, especially latent and chronic types, immunological methods determine a raised level of myosin light chain 1 molecules in the patient's blood |
| 02/16/2006 | DE102005008523A1 Analyseverfahren mit einem Doppelschlitzanalyse-Instrument für biologische Tests Methods of analysis with a dual slot analysis tool for biological tests |
| 02/16/2006 | DE102004062255B3 Portable process and assembly to determine and record blood sugar level for diabetics has test strip container with hinge flip electronic counter |
| 02/16/2006 | DE102004046326A1 Test device, useful e.g. for rapid protein detection in biological fluids, comprises transparent container with opening (where float and reagent mixture (e.g. polysaccharide) is present, and a suction device combined with the container |
| 02/16/2006 | DE102004038726A1 Test system, useful for rapid determination of Bence-Jones-protein, kappa or lambda free light chains in biological fluids, comprises reagent mixture comprising poly-, di-, monosaccharide and synthetic water-soluble polymer |
| 02/16/2006 | DE102004036358A1 Implantable dosing equipment for controlled release of medicinal substances, is connected to external unit by radio frequency transponder |
| 02/16/2006 | DE102004035623A1 Flowing fluid characteristic measurement unit for metal working and refining process and lubrication fluids measures reflected radiation from free surface |
| 02/16/2006 | DE102004035437A1 Verfahren und Vorrichtung zum Messen der Zügigkeit von pastösen Substanzen Method and apparatus for measuring the tack of pasty substances |
| 02/16/2006 | DE102004034666A1 Pigment holding textile support strip for linear water investigation has optically contrasting white oxide pigments of additional colorants released by solution |
| 02/16/2006 | DE10161829B4 Neue Methode zur Bestimmung der Telomerlänge und ihre Verwendung zur Abschätzung des Lebensalters New method for determination of telomere length and their use for the estimation of age |
| 02/16/2006 | CA2581262A1 New method for dopamine measurement and diagnoses and following up of psychosis |
| 02/16/2006 | CA2577601A1 Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system |
| 02/16/2006 | CA2576996A1 Non-invasive temperature and composition sensor for partially aqueous targets |
| 02/16/2006 | CA2576820A1 Method for measuring dynamics of self-assembling systems of biological molecules in vivo and uses for discovering or evaluating therapeutic agents |
| 02/16/2006 | CA2576702A1 Isolation, gene expression, and chemotherapeutic resistance of motile cancer cells |
| 02/16/2006 | CA2576415A1 Knockout nonhuman animal |
| 02/16/2006 | CA2576405A1 Antibody and utilization of the same |
| 02/16/2006 | CA2576295A1 Microarray-mediated diagnosis of herpes virus infection by monitoring host's differential gene expression upon injection |
| 02/16/2006 | CA2576108A1 Method and apparatus for the mobile pretreatment and analysis of catalysts containing precious metals |